We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Microfluidic Chip Developed For Ultrasensitive Glucose Detection

By LabMedica International staff writers
Posted on 18 May 2016
Highly sensitive and rapid detection of blood glucose is a diagnostic necessity in medicine as, for instance, lack of insulin and too much blood sugar are two main causes of diabetes, both of which can be detected by measuring blood glucose.

Fiber optics and microfluidics have been used to develop a cheap, ultra-sensitive lab-on-a-chip device that can quickly measure glucose in just a drop of sweat. More...
The technology behind it belongs to a new field called "optofluidics" that brings together photonic sensing (using the properties of light to detect chemicals) and microfluidics (precise control of tiny amounts of fluid along microchannels).

Scientists at the Hong Kong Polytechnic University (Kowloon, Hong Kong SAR, China) and their colleagues combined a new fiber optic biosensor with a microfluidic chip to create an interference-free optofluidic device for ultra-sensitive detection of glucose levels. The fiber optic sensor they created is very sensitive to changes in the refractive index of the material that surrounds it. To transform it into a glucose monitor, the team used a film of glucose oxidase as a sensing material as it reacts with glucose in solution.

To both support the sensing film and further enhance the signal, the team incorporated layers of two other materials - polyethylenimine (PEI) and polyacrylic acid (PAA), into the sensor. The result was several layers of PEI/PAA, with a top layer of glucose oxidase that was then embedded in the microchannel of the chip. After running several tests, the investigators found the fiber optic sensor was very sensitive on its own and can detect glucose oxidase concentrations as low as 1 nM, but after they integrated it into the microfluidic chip, the sensor's performance remarkably further improved. The sensor improved not only in detection range, but also in response time, which shortened from six minutes to 70 seconds.

A. Ping Zhang, PhD, an Assistant Professor and co-author of the study said, “Photonic approaches are seen as one of the most promising techniques for ultra-sensitive sensing, and when you integrate photonics with the tiny platform that microfluidic chips offer, you can make a small lab-on-a-chip analysis system for fast and reliable results.” The study was published on April 28, 2016, in the journal Biomedical Optics Express.

Related Links:
Hong Kong Polytechnic University


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.